Neuberger Berman Group
SANA icon

Neuberger Berman Group’s Sana Biotechnology SANA Stock Holding History

Neuberger Berman Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.1K Sell
12,066
-2,261
-16% -$7.28K ﹤0.01% 2299
2026
Q1 		$41.3K Buy
14,327
+3,581
+33% +$14.1K ﹤0.01% 2122
2025
Q4 		$43.7K Sell
10,746
-432
-4% -$1.93K ﹤0.01% 2061
2025
Q3 		$39.7K Buy
11,178
+251
+2% +$907 ﹤0.01% 2005
2025
Q2 		$29.8K Buy
10,927
+698
+7% +$1.44K ﹤0.01% 2006
2025
Q1 		$17.2K Buy
+10,229
New +$28.6K ﹤0.01% 1946

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Neuberger Berman Group's SANA Position: Q2 2026 in Review

Neuberger Berman Group reduced its Sana Biotechnology (SANA) stake by 16% in Q2 2026, selling an estimated $7.28K and leaving 12,066 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

Neuberger Berman Group first reported a position in SANA in Q1 2025 and has held it in 6 quarters since. The position peaked at $43.7K in Q4 2025. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Neuberger Berman Group held 12,066 shares of Sana Biotechnology worth $42.1K as of Q2 2026.
  • Neuberger Berman Group sold 2,261 Sana Biotechnology shares in Q2 2026, an estimated $7.28K.
  • Sana Biotechnology made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2299 holding.
  • Neuberger Berman Group first reported a position in Sana Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • Neuberger Berman Group's Sana Biotechnology position peaked at $43.7K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.